View in EDS PDF Full Text

The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation.

Saved in:
Bibliographic Details
Title: The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation.
Authors: Vanthienen W; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium., Fernández-García J; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Baietti MF; TRACE PDX Platform, Laboratory of RNA Cancer Biology, LKI Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Claeys E; TRACE PDX Platform, Laboratory of RNA Cancer Biology, LKI Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Van Leemputte F; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium., Nguyen L; Screening Core, VIB, Ghent, Belgium.; Centre for Bioassay Development and Screening (C-BIOS), Ghent University, Ghent, Belgium., Goossens V; Screening Core, VIB, Ghent, Belgium.; Centre for Bioassay Development and Screening (C-BIOS), Ghent University, Ghent, Belgium., Deparis Q; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium., Broekaert D; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Vlayen S; LKI Leuven Cancer Institute Leuven, KU Leuven, Leuven, Belgium., Audenaert D; Screening Core, VIB, Ghent, Belgium.; Centre for Bioassay Development and Screening (C-BIOS), Ghent University, Ghent, Belgium., Delforge M; LKI Leuven Cancer Institute Leuven, KU Leuven, Leuven, Belgium., D'Amuri A; Anatomic Pathology Unit, 'A. Perrino' Hospital, Brindisi, Italy., Van Zeebroeck G; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium., Leucci E; TRACE PDX Platform, Laboratory of RNA Cancer Biology, LKI Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Fendt SM; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Thevelein JM; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium.; NovelYeast bv, Bio-Incubator, BIO4, Leuven-Heverlee, Belgium.
Source: Frontiers in oncology [Front Oncol] 2024 Aug 22; Vol. 14, pp. 1411983. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39239276
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The novel family of Warbicin<superscript>®</superscript> compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vanthienen+W%22">Vanthienen W</searchLink>; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium.<br /><searchLink fieldCode="AU" term="%22Fernández-García+J%22">Fernández-García J</searchLink>; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Baietti+MF%22">Baietti MF</searchLink>; TRACE PDX Platform, Laboratory of RNA Cancer Biology, LKI Leuven Cancer Institute, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Claeys+E%22">Claeys E</searchLink>; TRACE PDX Platform, Laboratory of RNA Cancer Biology, LKI Leuven Cancer Institute, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Leemputte+F%22">Van Leemputte F</searchLink>; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium.<br /><searchLink fieldCode="AU" term="%22Nguyen+L%22">Nguyen L</searchLink>; Screening Core, VIB, Ghent, Belgium.; Centre for Bioassay Development and Screening (C-BIOS), Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Goossens+V%22">Goossens V</searchLink>; Screening Core, VIB, Ghent, Belgium.; Centre for Bioassay Development and Screening (C-BIOS), Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Deparis+Q%22">Deparis Q</searchLink>; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium.<br /><searchLink fieldCode="AU" term="%22Broekaert+D%22">Broekaert D</searchLink>; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Vlayen+S%22">Vlayen S</searchLink>; LKI Leuven Cancer Institute Leuven, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Audenaert+D%22">Audenaert D</searchLink>; Screening Core, VIB, Ghent, Belgium.; Centre for Bioassay Development and Screening (C-BIOS), Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Delforge+M%22">Delforge M</searchLink>; LKI Leuven Cancer Institute Leuven, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22D'Amuri+A%22">D'Amuri A</searchLink>; Anatomic Pathology Unit, 'A. Perrino' Hospital, Brindisi, Italy.<br /><searchLink fieldCode="AU" term="%22Van+Zeebroeck+G%22">Van Zeebroeck G</searchLink>; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium.<br /><searchLink fieldCode="AU" term="%22Leucci+E%22">Leucci E</searchLink>; TRACE PDX Platform, Laboratory of RNA Cancer Biology, LKI Leuven Cancer Institute, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Fendt+SM%22">Fendt SM</searchLink>; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Thevelein+JM%22">Thevelein JM</searchLink>; Center for Microbiology, VIB, Leuven-Heverlee, Belgium.; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium.; NovelYeast bv, Bio-Incubator, BIO4, Leuven-Heverlee, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Aug 22; Vol. 14, pp. 1411983. <i>Date of Electronic Publication: </i>2024 Aug 22 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39239276
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2024.1411983
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1411983
    Titles:
      – TitleFull: The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vanthienen W
      – PersonEntity:
          Name:
            NameFull: Fernández-García J
      – PersonEntity:
          Name:
            NameFull: Baietti MF
      – PersonEntity:
          Name:
            NameFull: Claeys E
      – PersonEntity:
          Name:
            NameFull: Van Leemputte F
      – PersonEntity:
          Name:
            NameFull: Nguyen L
      – PersonEntity:
          Name:
            NameFull: Goossens V
      – PersonEntity:
          Name:
            NameFull: Deparis Q
      – PersonEntity:
          Name:
            NameFull: Broekaert D
      – PersonEntity:
          Name:
            NameFull: Vlayen S
      – PersonEntity:
          Name:
            NameFull: Audenaert D
      – PersonEntity:
          Name:
            NameFull: Delforge M
      – PersonEntity:
          Name:
            NameFull: D'Amuri A
      – PersonEntity:
          Name:
            NameFull: Van Zeebroeck G
      – PersonEntity:
          Name:
            NameFull: Leucci E
      – PersonEntity:
          Name:
            NameFull: Fendt SM
      – PersonEntity:
          Name:
            NameFull: Thevelein JM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 08
              Text: 2024 Aug 22
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1